Michael L. Krachon serves as Vice President of Business Development, where he is responsible for providing leadership and direction for the company’s strategic growth initiatives. Michael joined the company in March 2021.
Prior to Theragenics, Michael served as Executive Vice President of Sales and Marketing for Isoray Medical, a manufacturer of Cesium-131 for brachytherapy treatments, and as Marketing Director for C.R. Bard, where he was a key member of the Bard Urological / Bard Medical Divisions which developed brachytherapy devices and delivery systems for the U.S. and international markets.
Michael earned a bachelor’s degree in biomedical engineering from Duke University and an Masters of Business Administration from the Goizueta Business School at Emory University.